Literature DB >> 2863493

Immunological paralysis to pneumococcal polysaccharide in man.

M E Pichichero.   

Abstract

A 9-month-old infant had severe pneumococcal meningitis and for the next two years showed immunological paralysis to the causal serotype. He remained normally responsive to a protein antigen (tetanus toxoid) and to polysaccharide antigens (Haemophilus influenzae type b capsule and pneumococcal capsule antigens other than the infecting/paralysing serotype). By the fourth year of life the child was spontaneously producing antibody to the infecting/paralysing pneumococcal serotype, at which time rechallenge with the previously tolerising antigen resulted in a secondary response. The occurrence of pneumococcal immunological paralysis in man is therefore validated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863493     DOI: 10.1016/s0140-6736(85)90401-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.

Authors:  F M Russell; J R Carapetis; A Balloch; P V Licciardi; A W J Jenney; L Tikoduadua; L Waqatakirewa; J Pryor; J Nelson; G B Byrnes; Y B Cheung; M L K Tang; E K Mulholland
Journal:  Vaccine       Date:  2010-03-04       Impact factor: 3.641

2.  Deficiency of immunity to Mycobacterium avium that can be restored by allogeneic lymphocytes.

Authors:  J D Schot; D Elferink; H Hooijkaas; H J Neijens; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

3.  Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia.

Authors:  Daniel M Musher; Adriana M Rueda; Moon H Nahm; Edward A Graviss; Maria C Rodriguez-Barradas
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

4.  Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal disease.

Authors:  Ray Borrow; Elaine Stanford; Pauline Waight; Matthew Helbert; Paul Balmer; Rosalind Warrington; Mary Slack; Robert George; Elizabeth Miller
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441

5.  A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease.

Authors:  Fabian Uddén; Jonas Ahl; Nils Littorin; Kristoffer Strålin; Simon Athlin; Kristian Riesbeck
Journal:  mSphere       Date:  2020-02-05       Impact factor: 4.389

6.  Pneumococcal polysaccharide abrogates conjugate-induced germinal center reaction and depletes antibody secreting cell pool, causing hyporesponsiveness.

Authors:  Stefania P Bjarnarson; Hreinn Benonisson; Giuseppe Del Giudice; Ingileif Jonsdottir
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.